22nd Century Group Inc. Common Stock (XXII)

FairStock Score: 56/100 — STEADY

Key Financials

AI Analysis

AI-generated, general educational analysis — not personal investment advice.

I start with earning power, not a low stock price. 22nd Century sells reduced-nicotine tobacco and contract cigarettes, but in fiscal Q2 2026, the quarter ended 2026-06-30, filed revenue was $2.9 million and net loss was $3.3 million. Full-year 2025 revenue was $17.6 million with a $5.1 million net loss, down from $24.4 million of revenue and a $15.2 million loss in full-year 2024; full-year 2023 revenue was $32.2 million with a $140.8 million loss. That is a shrinking business, and I see no durable competitive moat in the reported figures. Financial health is poor where it matters. Trailing free cash flow was -$9.5 million, and FairStock's FCF yield is -769.5% against a $1.2 million market cap. Debt-to-equity of 0.09 is a small comfort, but cash burn dominates. FairStock's Piotroski F-Score is 2/9 and its Altman Z-Score is -21.49, which do not describe a sturdy enterprise. The Lynch category is none because the company lost money in each of the last four years. At the 2026-10-26 close of $0.09, FairStock shows P/E and P/B of 0.00 and a Graham Number of $1,389.40 with a 99.99% margin of safety. Those valuation outputs are not trustworthy when earnings are negative and per-share data are distorted; I would not treat them as real safety. Growth is negative, losses persist, and the equity is speculative.

In plain English: 22nd Century makes reduced-nicotine tobacco and also makes cigarettes for other brands. The business looks weak: sales are falling, it keeps losing money, and it burns cash. At 9 cents a share, the price looks very low, but the reported numbers do not show a healthy, cheap business.

The full AI analysis, bull and bear case and key monitorables are in FairStock Pro.

Data as of 2026-10-26 close · note generated 2026-10-28 · model deepseek-flash

Sources (SEC EDGAR): fiscal Q2 2026 10-Q (period ended 2026-06-30) · fiscal Q1 2026 10-Q (period ended 2026-03-31) · fiscal Q3 2025 10-Q (period ended 2025-09-30) · fiscal Q2 2025 10-Q (period ended 2025-06-30) · FY2025 10-K (period ended 2025-12-31) · FY2024 10-K (period ended 2024-12-31) · FY2023 10-K (period ended 2023-12-31)

Fundamentals from company filings and market-data providers; prices are end-of-day, not real-time. AI-generated analysis is general and educational — not personal investment advice. Scoring methodology · Score test · Disclaimer